Conversant Bio Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Merger of Eq.

  • Financing Rounds
  • 1

  • Investments
  • 2

Conversant Bio General Information


Provider of biospecimen services intended for oncology and rheumatology research. The company's services including procurement of human primary cells from peripheral blood, bone marrow, processed and whole tissue as well as assessment of tumor tissues for scientific investigations, enable clients to develop new medicines and diagnostic tools.

Contact Information

Ownership Status
Financing Status
Corporate Backed or Acquired
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Other Healthcare Services
Corporate Office
  • 601 Genome Way
  • Suite 1200
  • Huntsville, AL 35806
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Conversant Bio Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Conversant Bio‘s full profile, request access.

Request a free trial

Conversant Bio Comparisons

HQ Location
Total Raised
Post Valuation
Provider of biospecimen services intended for oncology and rheumatology research. The company's services including procu
Laboratory Services (Healthcare)
Huntsville, AL


etur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna
0000000000 00000000
Brisbane, CA
00 As of 0000

000 00

liqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi u
Folsom, CA
00 As of 0000
000000000 -
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Conversant Bio Competitors (7)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cureline Corporation Brisbane, CA 00
CGT GLOBAL Corporation Folsom, CA 00 000000000 -
SourceBio International Formerly PE-Backed Nottingham, United Kingdom 000 000.00 00000000000 000.00
DiaCarta Venture Capital-Backed Pleasanton, CA 00 0000 000000000000
Discovery Life Sciences Private Equity-Backed Huntsville, AL 000 00000 0000000 0000 00000
You’re viewing 5 of 7 competitors. Get the full list »

Conversant Bio Patents

Conversant Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20060101063-A1 Method for the collection and analysis of medical data Inactive 05-Nov-2004 000000000 0

Conversant Bio Investments (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Aurora Health Care 24-Mar-2015 00000 0000 Clinics/Outpatient Services 00000000
Entopsis 18-Mar-2015 Seed Round 00000 Diagnostic Equipment
To view Conversant Bio’s complete investments history, request access »

Conversant Bio Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
Aurora Health Care 24-Mar-2015 00000 0000 Completed
  • 0000000000 000
To view Conversant Bio’s complete exits history, request access »

Conversant Bio FAQs

  • When was Conversant Bio founded?

    Conversant Bio was founded in 2006.

  • Who is the founder of Conversant Bio?

    Marshall Schreeder Jr. and Luke Doiron are the founders of Conversant Bio.

  • Where is Conversant Bio headquartered?

    Conversant Bio is headquartered in Huntsville, AL.

  • What industry is Conversant Bio in?

    Conversant Bio’s primary industry is Laboratory Services (Healthcare).

  • Is Conversant Bio a private or public company?

    Conversant Bio is a Private company.

  • What is Conversant Bio’s current revenue?

    The current revenue for Conversant Bio is 000000.

  • Who are Conversant Bio’s competitors?

    Cureline, CGT GLOBAL, SourceBio International, DiaCarta, and Discovery Life Sciences are some of the 7 competitors of Conversant Bio.

  • When was Conversant Bio acquired?

    Conversant Bio was acquired on 01-Feb-2018.

  • Who acquired Conversant Bio?

    Conversant Bio was acquired by Discovery Life Sciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »